Treatment of Candidiasis with Ketoconazole

[1]  D. Bartley,et al.  Ketoconazole and candidiasis: a controlled study. , 1983, The Journal of infectious diseases.

[2]  D. Rotrosen,et al.  Adherence of candida species to intravenous catheters. , 1983, The Journal of infectious diseases.

[3]  J. Graybill,et al.  High-dose ketoconazole for treatment of fungal infections of the central nervous system. , 1983, Annals of internal medicine.

[4]  J. Cutsem The antifungal activity of ketoconazole , 1983 .

[5]  F. Meunier-Carpentier Treatment of mycoses in cancer patients. , 1983, The American journal of medicine.

[6]  C. Kirkpatrick,et al.  Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. , 1983, The American journal of medicine.

[7]  D. Stevens,et al.  Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. , 1983, The American journal of medicine.

[8]  B. Dupont,et al.  Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. , 1983, The American journal of medicine.

[9]  J. Galgiani,et al.  Ketoconazole therapy for fungal urinary tract infections. , 1983, The Journal of urology.

[10]  D. Stevens,et al.  Ketoconazole blocks testosterone synthesis. , 1982, Archives of internal medicine.

[11]  J. Najarian,et al.  KETOCONAZOLE, CYCLOSPORIN METABOLISM, AND RENAL TRANSPLANTATION , 1982, The Lancet.

[12]  D. Stevens,et al.  Ketoconazole blocks adrenal steroid synthesis. , 1982, Annals of internal medicine.

[13]  G. Medoff,et al.  Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics. , 1982, The Journal of infectious diseases.

[14]  J. Perfect,et al.  Failure of ketoconazole in cryptococcal meningitis. , 1982, JAMA.

[15]  H. Prentice,et al.  KETOCONAZOLE VERSUS NYSTATIN PLUS AMPHOTERICIN B FOR FUNGAL PROPHYLAXIS IN SEVERELY IMMUNOCOMPROMISED PATIENTS , 1982, The Lancet.

[16]  C. Stratton,et al.  Candidal suppurative peripheral thrombophlebitis. , 1982, Annals of internal medicine.

[17]  T. Blaschke,et al.  Disposition of ketoconazole, an oral antifungal, in humans , 1982, Antimicrobial Agents and Chemotherapy.

[18]  D. A. J. Firebrace Hepatitis and ketoconazole therapy , 1981, British medical journal.

[19]  M. Borgers,et al.  The Activity of Ketoconazole on Clinical Isolates of Candida Albicans Cultured in a Mycelium Promoting Medium Die Wirkung von Ketoconazol auf Candida albicans aus klinischem Material unter Verwendung eines Mediums, das die Myzelbildung stimuliert. , 1981 .

[20]  E. Svejgaard,et al.  Toxic hepatis during ketoconazole treatment. , 1981, British medical journal.

[21]  D. Armstrong,et al.  Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. , 1981, The American journal of medicine.

[22]  P. Pizzo Infectious complications in the child with cancer. II. Management of specific infectious organisms. , 1981, The Journal of pediatrics.

[23]  D. Alling,et al.  Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. , 1980, Annals of internal medicine.

[24]  J. Graybill,et al.  Ketoconazole: a major innovation for treatment of fungal disease. , 1980, Annals of internal medicine.

[25]  J. Jones Necrotizing Candida esophagitis. Failure of symptoms and roentgenographic findings to reflect severity. , 1980, JAMA.

[26]  E. Stiehm,et al.  Successful treatment of chronic mucocutaneous candidiasis with ketoconazole. , 1980, The Journal of pediatrics.

[27]  J. V. D. van der Meer,et al.  CSF concentrations of ketoconazole. , 1980, The Journal of antimicrobial chemotherapy.

[28]  V. Schuermans,et al.  An evaluation of two years of clinical experience with ketoconazole. , 1980, Reviews of infectious diseases.

[29]  M. De Brabander,et al.  The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. , 1980, Sabouraudia.

[30]  H. van den Bossche,et al.  In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis , 1980, Antimicrobial Agents and Chemotherapy.

[31]  G. Medoff,et al.  Strategies in the treatment of systemic fungal infections. , 1980, The New England journal of medicine.

[32]  S. Touri,et al.  Oesophageal moniliasis causing fistula formation and lung abscess. , 1976, Thorax.

[33]  W. Krause,et al.  Fungaemia and funguria after oral administration of Candida albicans. , 1969, Lancet.